Candidate Genes in Patients with Autoinflammatory Syndrome Resembling Tumor Necrosis Factor Receptor-associated Periodic Syndrome Without Mutations in the TNFRSF1A Gene
Authors:
- Silvia BorghiniSBSilvia Borghini
- Michele FioreMFMichele Fiore
- Marco Di DucaMDMarco Di Duca
- Francesco CaroliFCFrancesco Caroli
- Martina FinettiMFMartina Finetti
- Giuseppe SantamariaGSGiuseppe Santamaria
- Francesca FerlitoFFFrancesca Ferlito
- Federico BuaFBFederico Bua
- Paolo PiccoPPPaolo Picco
- Laura ObiciLOLaura Obici
- Alberto MartiniAMAlberto Martini
- Marco GattornoMGMarco Gattorno
- 1 April 2011
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 38 (7) , 1378-1384
Abstract
Objective.: Tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) is an autosomal-dominant multisystemic autoinflammatory condition. Patients display different mutations of the TNF receptor superfamily 1A gene (TNFRSF1A), coding for a nearly ubiquitous TNF receptor (TNFR1). No TNFRSF1A mutation has been identified in a proportion of patients with TRAPS-like phenotype.Methods.: We investigated mechanisms downregulating the TNF-induced inflammatory response such as (1) receptor shedding, producing a secreted form acting as a TNF inhibitor; (2) receptor internalization with subsequent induction of apoptosis; and (3) negative regulation of nuclear factor-κB (NF-κB) transcription. We analyzed the sequence of genes known to play a pivotal role in these pathways, in 5 patients with TRAPS symptoms and showing shedding and/or apoptosis defects, but without mutations of the TNFRSF1A gene.Results.: Sequence analysis of 3 genes involved in TNFR1 shedding (ERAP1, NUCB2, RBMX) and 3 genes involved in negative regulation of NF-κB signaling (TNFAIP3, CARP-2) or NF-κB transcription (ZFP36) revealed only a few unreported variants, apparently neutral.Conclusion.: Our study rules out any involvement in the pathogenesis of TRAPS of some of the genes known to regulate TNFR1 shedding and TNF-induced NF-κB signaling and transcription. Gene(s) responsible for TRAPS-like syndrome remain to be investigated among currently unidentified genes likely involved in these pathways, or by applying the genome-wide function-free sequencing approach.Keywords
This publication has 17 references indexed in Scilit:
- Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndromeProceedings of the National Academy of Sciences, 2010
- The ubiquitin‐editing enzyme A20 requires RNF11 to downregulate NF‐κB signallingThe EMBO Journal, 2009
- An association between RBMX, a heterogeneous nuclear ribonucleoprotein, and ARTS-1 regulates extracellular TNFR1 releaseBiochemical and Biophysical Research Communications, 2008
- Extracellular TNFR1 Release Requires the Calcium-dependent Formation of a Nucleobindin 2-ARTS-1 ComplexJournal of Biological Chemistry, 2006
- Life And Death DecisionsImmunity, 2004
- Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: A mechanism for generation of soluble cytokine receptorsProceedings of the National Academy of Sciences, 2004
- Heterogeneity among patients with tumor necrosis factor receptor–associated periodic syndrome phenotypesArthritis & Rheumatism, 2003
- Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain sheddingJournal of Clinical Investigation, 2002
- The Tumor-Necrosis-Factor Receptor–Associated Periodic Syndrome: New Mutations in TNFRSF1A, Ancestral Origins, Genotype-Phenotype Studies, and Evidence for Further Genetic Heterogeneity of Periodic FeversThe American Journal of Human Genetics, 2001
- Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory SyndromesCell, 1999